371 related articles for article (PubMed ID: 8797532)
1. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
[TBL] [Abstract][Full Text] [Related]
2. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Kilbourn MR; Kuszpit K; Sherman P
Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
Brown JM; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
[TBL] [Abstract][Full Text] [Related]
4. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
6. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A
J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
8. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
9. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
[TBL] [Abstract][Full Text] [Related]
10. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.
Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC
J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484
[TBL] [Abstract][Full Text] [Related]
11. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
Brown JM; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2001 Sep; 298(3):1150-3. PubMed ID: 11504813
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.
Kilbourn MR; Kemmerer ES; Desmond TJ; Sherman PS; Frey KA
Exp Neurol; 2004 Aug; 188(2):387-90. PubMed ID: 15246838
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in dopamine- and vesicular monoamine-transporter functions.
Dluzen DE; McDermott JL
Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
[TBL] [Abstract][Full Text] [Related]
16. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
17. [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum.
Gracz LM; Madras BK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1224-34. PubMed ID: 7791095
[TBL] [Abstract][Full Text] [Related]
18. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain.
De La Garza R; Meltzer PC; Madras BK
Synapse; 1999 Oct; 34(1):20-7. PubMed ID: 10459168
[TBL] [Abstract][Full Text] [Related]
19. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content.
Bemis JC; Seegal RF
Toxicol Sci; 2004 Aug; 80(2):288-95. PubMed ID: 15115888
[TBL] [Abstract][Full Text] [Related]
20. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]